• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

GSA Renews Contract with Xenex LightStrike Germ-Zapping Robots

by Syed Hamza Sohail 08/05/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Xenex Disinfection Services has announced the 5-year renewal of its U.S. General Services Administration (GSA) contract, which enables federal agencies (including Veterans Affairs and U.S. Department of Defense healthcare facilities) to easily deploy Xenex’s powerful LightStrike™ room disinfection technology.

– In addition to federal agencies, the GSA contract supports the procurement needs of eligible state, local, territorial, and tribal governments (including schools). 

The Need to Disinfect

Studies show that less than half the surfaces in a patient room are disinfected when it’s being cleaned and prepared for the next patient. Pathogens such as Clostridium difficile(C.diff), methicillin-resistant Staphylococcus aureus (MRSA), Acinetobacter, and Candida auris that may be left behind on high-touch surfaces can transmit from patient to patient or patient to healthcare worker. Some deadly superbugs are showing resistance to cleaning chemicals, making the pathogens even more difficult to remove.

LightStrike Germ-Zapping Robots™, which first became available via GSA contract in 2012, provides a fast and effective way to disinfect healthcare facilities. More than 130 government healthcare facilities including VA, Army, Navy, Air Force, and Marine Corps hospitals use Xenex LightStrike robots for daily room disinfection. In 2012, the W. G. (Bill) Hefner VA Medical Center in Salisbury, NC was the first VA hospital to deploy four LightStrike robots and today utilizes its 11 LightStrike robots to disinfect ORs, ICUs, patient rooms, the Emergency Department, catheterization lab, oncology, dialysis, public restrooms and much more.

The LightStrike robot utilizes intense bursts of pulsed xenon ultraviolet (UV) light to quickly deactivate viruses, bacteria and spores on surfaces and is effective against even the most dangerous superbugs and multi-drug resistant organisms, including MRSA, C.diff, and SARS-CoV-2 (the virus that causes COVID-19). Additionally, the LightStrike robot has been proven effective against both the Ebola virus and Anthrax and can easily be incorporated into a facility’s biodefense strategy.

“There’s never been a more important time to have a disinfected environment. Viruses and bacteria are becoming resistant to chemicals, antibiotics and even some hand sanitizers. We are honored to be part of the disinfection strategy for the VA and DOD hospitals using LightStrike robots for room disinfection. Protecting the environment for those who protect us every day is an honor and we are committed to helping our government customers every step of the way,” said Joe Monroe, vice president of U.S. sales for Xenex.

Scientific Validation and Environmental Protection for Government Facilities

More than 45 peer-reviewed studies have been published validating the efficacy of LightStrike technology. The Central Texas Veterans Healthcare System is a pioneer in the utilization of UV technology for room disinfection and has conducted numerous studies about LightStrike pulsed xenon UV robots. One study published in the American Journal of Infection Control indicates that pulsed xenon-based ultraviolet light systems effectively reduce aerobic bacteria in the absence of manual disinfection.

Xenex robots are designed and manufactured in the U.S. and use pulsed xenon lamps (not mercury bulbs) to generate broad spectrum UV light. The robots don’t require warm-up or cool-down time, and don’t harm surfaces or expensive hospital equipment like mercury lamp UV products. In 2009, the U.S. Department of Energy issued an Executive Order for federal agencies to become more protective of the environment in practices including the use of non-toxic or less toxic alternatives when possible where these products meet the performance requirements of the agency.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: department of defense, Germ-Zapping Robots, honor, Oncology

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |